Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.

Charo, Lindsey M; Eskander, Ramez N; Okamura, Ryosuke; Patel, Sandip P; Nikanjam, Mina; Lanman, Richard B; Piccioni, David E; Kato, Shumei; McHale, Michael T; Kurzrock, Razelle

Charo, Lindsey M; Eskander, Ramez N; Okamura, Ryosuke; Patel, Sandip P; Nikanjam, Mina; Lanman, Richard B; Piccioni, David E; Kato, Shumei; McHale, Michael T; Kurzrock, Razelle.

Afiliação

Charo LM; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Eskander RN; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Okamura R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Patel SP; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Nikanjam M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Lanman RB; Guardant Health, Inc., Redwood City, CA, USA.
Piccioni DE; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
McHale MT; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.

Mol Oncol ; 15(1): 67-79, 2021 01.

Article em En | MEDLINE | ID: mdl-32881280

Assuntos

DNA Tumoral Circulante/sangue; Neoplasias dos Genitais Femininos/sangue; Adulto; Idoso; Idoso de 80 Anos ou mais; Biópsia; Feminino; Frequência do Gene/genética; Neoplasias dos Genitais Femininos/patologia; Humanos; Pessoa de Meia-Idade; Análise Multivariada; Mutação/genética; Prognóstico; Análise de Sobrevida; Fatores de Tempo

Palavras-chave

circulating tumor DNA; gynecologic cancer; liquid biopsy; matched therapy; mutation allele frequency; next-generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Tumoral Circulante / Neoplasias dos Genitais Femininos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google